Elevated CA15-3 or CEA or CA27-29 trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Elevated CA15-3 or CEA or CA27-29 trials nationally

Cities in Illinois

Recruiting trials in Illinois

• S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
  NCT03723928 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Alton, Aurora, Bloomington, Burr Ridge